For patients with advanced non-small cell lung cancer and anorexia, the use of the antidepressant Remeron has been shown to increase energy consumption, as researchers look for therapies to answer an ...
> Organon USA Inc., a subsidiary of Merck & Co., agreed to pay $31 million to resolve allegations of overcharging Medicaid programs for Remeron, an antidepressant sold at a discount to pharmacy ...
Organon, the pharmaceutical arm of Azko Nobel, has filed a new drug application in Japan for its antidepressant Remeron, along with partner Meiji Seika Kaisha. Organon, the pharmaceutical arm of Azko ...
Alternative to Meds Center Shares Clinical Perspective on Remeron Tapering and Safer Discontinuation
SEDONA, AZ, UNITED STATES, January 27, 2026 /EINPresswire.com/ — Alternative to Meds Center, a licensed residential mental health treatment facility in Sedona ...
Akzo Nobel this morning said it had settled the remaining antitrust claims concerning its antidepressant, Remeron (mirtazapine), for $75 million dollars. The lawsuits, filed by drug wholesalers, ...
Akzo Nobel, the Dutch pharmaceuticals, coatings and chemical company, said it had reached a $59.8 million settlement of antitrust litigation in the U.S. over its blockbuster antidepressant drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results